I do have one whinge about the ann though. The headline says...

I do have one whinge about the ann though. The headline says that Travelan prevented shigella in 75% of cases, however reading on it's clear that it's actually 87.5% of cases and that a second case was only contracted after treatment stopped.

While you can't get too fussy when it's a sample size of 8 (I'd guess the DoD would be happy with 75%) the results are slightly better than the headline.

I'd note that anns like this often take a day or two before people pick up on them. So while it'd be foolish to make share price predictions, maybe this will go up, just not for a day or so.